申请人:HEXAL AS
公开号:WO2005066190A1
公开(公告)日:2005-07-21
New risedronate salts selected among disodium risedronate, monopotassium risedronate, dipotassium risedronate, monoammonium risedronate, diammonium risedronate, hemipiperazine risedronate, ethanolamine risedronate and morpholinoethanolamine risedronate and hydrates thereof are disclosed. The new salts have a very low tendency to incorporate additional water into their crystals, which make these salts stable during storage in ambient air. Further pharmaceutical compositions comprising the new risedronate salts and hydrates thereof are disclosed.
本发明公开了一种新型的瑞舒伐他汀盐,包括二钠瑞舒伐他汀、单鉀瑞舒伐他汀、二鉀瑞舒伐他汀、单铵瑞舒伐他汀、双铵瑞舒伐他汀、半哌嗪瑞舒伐他汀、乙醇胺瑞舒伐他汀和吗啡啶乙醇胺瑞舒伐他汀及其水合物。这些新型盐的结晶具有很低的吸水性,使得这些盐在常温下储存时非常稳定。此外,本发明还公开了包含这些新型瑞舒伐他汀盐及其水合物的制药组合物。